Author:
Kang Ji-Young,Mun Dasom,Chun Yumin,Kim Hyoeun,Yun Nuri,Lee Seung-Hyun,Joung Boyoung
Subject
Cell Biology,Developmental Biology,General Medicine
Reference5 articles.
1. Alpha-tropomyosin mutations in inherited cardiomyopathies;Redwood;J. Muscle Res. Cell Motil.,2013
2. Sarcomere gene mutations in isolated left ventricular noncompaction cardiomyopathy do not predict clinical phenotype;Probst;Circ.-Cardiovasc. Genet.,2011
3. Loss of crossbridge inhibition drives pathological cardiac hypertrophy in patients harboring the TPM1 E192K mutation;Sewanan;J. Gen. Physiol.,2021
4. Clinical insights into heritable cardiomyopathies;Martinez;Front. Genet.,2021
5. Cha, Y. J., Jeon, S. B., Oh, J., Lee, S. T., Kim, S., Kim, H., Choi, J., Choi, H. K., Won, D., Choi, J. R., Kim, S. J., Park, S. W., Kang, S. M., Lee, S. H., 2022. Derivation of YCMi005-A, a human-induced pluripotent stem cell line, from a patient with dilated cardiomyopathy carrying missense variant in TPM1 (p. Glu192Lys). Stem cell Res. 60, 102707.